Marshfield Clinic Data Breach Claims Investigated by Lynch Carpenter

PITTSBURGH, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Marshfield Clinic Health System (“Marshfield Clinic”),1 recently announced a cybersecurity incident, which impacted the personal information of an unknown number of individuals. Lynch Carpenter, LLP is investigating claims against Marshfield Clinic related to this data breach. For an attorney to review your case, visit our site HERE.

In the incident, an unauthorized person gained access to Marshfield Clinic’s network and may have acquired records containing personally identifiable information (“PII”) and protected health information (“PHI”) that includes individuals’ names in combination with:
• address
• phone number
• date of birth
• insurance ID number
• medical record number
• dates of service
• treatment/diagnosis information
• lab results
• medications

If your information was impacted in this incident, you may be entitled to compensation. For an attorney to review your case, visit our site HERE.

If you have received any other data breach notice letters in the last 30 days, please contact us here.

About Lynch Carpenter

Lynch Carpenter is a national class action law firm with offices in Pennsylvania, California, and Illinois. Our firm has represented millions of clients in data privacy matters for more than a decade and has earned national acclaim for complex litigation for plaintiffs across the country. To learn more, please visit www.lynchcarpenter.com.

For more information, please call Jerry Wells at (412) 322-9243, or email him at [email protected].

CONTACT Jerry Wells
COMPANY Lynch Carpenter LLP
PHONE (412) 322-9243
EMAIL [email protected]
WEB lynchcarpenter.com

1 https://www.marshfieldclinic.org/

You May Also Be Interested In

• Enovix’s TAA-Compliant Battery Manufacturing Strengthens Position with U.S. Defense Supply Chain
• The American Diabetes Association Audit and Governance Committee Releases Independent Review
• PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting